PTCT Q1 2021 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$6B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$118M+72.8% YoY

Gross Profit

$109M92.3% margin

Operating Income

-$98M-83.2% margin

Net Income

-$129M-109.1% margin

EPS (Diluted)

$-1.83

QoQ Revenue Growth

-0.8%

Cash Flow

Operating Cash Flow

-$100M

Free Cash Flow

-$120M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$2.1B

Total Liabilities

$1.8B

Stockholders' Equity

$293M

Cash & Equivalents

$147M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$118M	$68M	+72.8%
Gross Profit	$109M	$64M	+69.6%
Operating Income	-$98M	-$93M	-5.5%
Net Income	-$129M	-$113M	-14.2%

Revenue Segments

Product

$91M100%